by Karl Utermohlen | January 17, 2014 3:30 pm
The Food and Drug Administration (FDA) has issued an acetaminophen warning to health professionals prescribing certain drugs.
The FDA made a statement on Tuesday asking health professionals to stop prescribing combination drugs with over 325 milligrams of acetaminophen per tablet. The agency issued the acetaminophen warning because a high dose of the drug can lead to severe liver damage including liver failure, liver transplant and death.
In January 2011, he FDA asked manufacturers to limit their capsules or tablets to 325 mg of acetaminophen by January 14, 2014. However, there are still some products in the market with over 325 mg of acetaminophen. One such product is Extra Strength Tylenol — owned by a Johnson & Johnson (JNJ) subsidiary — which has 500 mg of acetaminophen per dose.
JNJ stock is up 0.25% Friday.
Source URL: https://investorplace.com/2014/01/acetaminophen-warning/
Short URL: http://invstplc.com/1nwWadk
Copyright ©2018 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.